Lotemax
NDC Package 54868-4278-0
Package Information
Lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation.LOTEMAX is less effective than prednisolone acetate 1% in two 28-day controlled clinical studies in acute anterior uveitis, where 72% of patients treated with LOTEMAX experienced resolution of anterior chamber cells, compared to 87% of patients treated with prednisolone acetate 1%. Marketed by Physicians Total Care, Inc., this product is identified by NDC 54868-4278 and is authorized under FDA application NDA020583.
Identification & Billing
- RxCUI: 213263 - Lotemax 0.5 % Ophthalmic Suspension
- RxCUI: 213263 - loteprednol etabonate 5 MG/ML Ophthalmic Suspension [Lotemax]
- RxCUI: 213263 - Lotemax 5 MG/ML Ophthalmic Suspension
- RxCUI: 311382 - loteprednol etabonate 0.5 % Ophthalmic Suspension
- RxCUI: 311382 - loteprednol etabonate 5 MG/ML Ophthalmic Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54868 - Physicians Total Care, Inc.
- 54868-4278 - Lotemax
- 54868-4278-0 - 1 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE
- 54868-4278 - Lotemax
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54868-4278). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54868-4278-0 identifies a specific commercial package of 1 bottle in 1 carton / 15 ml in 1 bottle of Lotemax, labeled by Physicians Total Care, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 15 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Physicians Total Care, Inc. on October 17, 2002. The current certification is valid through December 31, 2017.
How is this Physicians Total Care, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54868427800. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 15 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.